Last updated on July 2019

Study to Evaluate the Efficacy Safety and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)


Brief description of study

This study is being conducted to evaluate in participants with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) the abdominal pain response to BOS-589 after 4 weeks of treatment and to evaluate the overall safety and tolerability of BOS-589 in the treatment of IBS-D during 4 weeks of treatment, relative to placebo (PBO).

Clinical Study Identifier: NCT03977155

Find a site near you

Start Over

Clinical Research Associates

Huntsville, AL United States
  Connect »

Elite Clinical Studies

Phoenix, AZ United States
  Connect »

Hope Research Institute LLC

Phoenix, AZ United States
  Connect »

Paragon Rx Clinical, Inc.

Garden Grove, CA United States
  Connect »

eStudySite

La Mesa, CA United States
  Connect »

Clinical Trials Research

Sacramento, CA United States
  Connect »

Millennium ClinicalTrials

Thousand Oaks, CA United States
  Connect »

Advanced Rx Clinical Research

Westminster, CA United States
  Connect »

Mayo Clinic

Jacksonville, FL United States
  Connect »

Sundance Clinical Research

Saint Louis, MO United States
  Connect »

NY Scientific

Brooklyn, NY United States
  Connect »

Peters Medical Research, LLC

High Point, NC United States
  Connect »

WR-ClinSearch, LLC

Chattanooga, TN United States
  Connect »

L12 Clinical Research

Dallas, TX United States
  Connect »

Southwest Clinical Trials

Houston, TX United States
  Connect »

Quality Research Inc.

San Antonio, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.